目的:探讨ERK通路是否参与TGF-β/Smad通路诱导的血管平滑肌细胞增殖及可能的分子机制。方法:原代培养大鼠胸主动脉平滑肌细胞,细胞分4组:(1)对照组;(2)TGF-β1组;(3)ERK阻断剂(PD98059)组;(4)TGF—β1+ERK阻断剂(PD98059)组。MTT法测细胞的增殖活性,Westernblotting法检测VSMCs中细胞内核增殖抗原(PCNA)、Smad2/3、ERK1/2、Smad7蛋白表达及相关磷酸化蛋白含量,RT—PCR方法测VSMCs中Smad2、3、7mRNA的表达。结果:(1)各组PCNA蛋白表达和MTT法测得A值均低于对照组(P〈0.05),TGF—β1+ERK阻断剂组与TGF—β1组相比无显著差异。(2)与对照组相比,TGF—β1组p—Smad2/3、p—ERK1/2蛋白含量和Smad7蛋白表达增高(P〈0.05),ERK阻断剂组则明显降低(P〈0.05);与TGF—β1组比,TGF—β1+ERK阻断剂组降低(P〈0.05)。各组间Smad2/3、ERK1/2蛋白表达无显著差异。(3)与对照组相比,TGF—β1组Smad7mRNA表达增高(P〈0.05),ERK阻断剂组和TGF—β1+ERK阻断剂组降低(P〈0.05);与TGF—β1组比,TGF—β1+ERK阻断剂组表达降低(P〈0.05)。各组内VSMCs的Smad2、Smad3mRNA表达无显著差异。结论:(1)TGF—β1诱导的Smad2/3蛋白磷酸化依赖ERK通路激活,但对TGF—β1的抑制平滑肌细胞增殖的作用无影响,可能有其它信号通路参与此过程。(2)ERK通路可通过蛋白和mRNA水平促进Smad7表达,反过来其又可促进ERK通路激活。(3)ERK通路对Smad2/3蛋白和mRNA水平无影响。
AIM: To investigate whether extracellular signal regulated kinase (ERK) pathway participates the proliferation of vascular smooth muscle ceils (VSMCs) that is regnlated by transforming growth factorβ(TGF- β)/Smad pathway. METHODS: The rat's aorta were removed. The primary VSMCs were isolated and cultured in vitro, then the VSMCs were divided into four groups: ( 1 ) control group; (2) TGF - β1 group; (3) ERK blocking agent group; (4) TGF- β1 + ERK blocking agent group. The prollferation of VSMCs was detected by MTT, the expressions of PCNA, Smad2/3, ERK1/2, Smad7 proteins, the content of phosphorylated ERK1/2 and Smad2/3 proteins were determined by Western blotting and the expressions of Smad2/3, Smad7 mRNA were measured by reverse transcription - polymerase chain reaction (RT -PCR). RESUILTS : (1) The expression of PCNA proteins and A value in other groups were decreased obviously compared with control group (P 〈 0. 05 ), and no difference between the TGF- β1 group and .the TGF-β1 + ERK blocking agent group was observed. (2) The content of phosphorylated Smad2/3, ERK1/2 proteins and the expression of Smad7 proteins in TGF - β1 group were increased ( P 〈 0. 05 ), and decreased in ERK blocking agent group ( P 〈 0. 05 ), compared with control group. The content of phosphorylated Smad2/3, ERK1/2 proteins and the expression of Smad7 proteins in TGF - β1 + ERK blocking agent group were decreased compared with TGF - β1 group (P 〈0. 05). No difference in the expression of Smad2/3, ERK1/2 proteins among different groups was found. (3) The expression of Smad7 mRNA in TGF - β1 group was increased compared with control group (P 〈 0. 05 ), and decreased in ERK blocking agent and TGF -β1 + ERK blocking agent groups (P 〈0. 05). Compared with TGF -β1 group, the expression of Smad7 mRNA in TGF - β1 + ERK blocking agent group was decreased (P 〈 0. 05 ). There was no difference in Smad2 and Smad3 mRNA among differe